Vericel Corp (VCEL)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $312k
- Aug 12 · Routine
- Form 4 sales
- 145
- On record
- Form 144 notices
- 24
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleRoutineJun 18 2026
Sold 10,000 shares at $40.24 ($402k)
Halpin Michael, Chief Operating Officer
10b5-1 planSold 38.1% of holdings ($1.1M position)16,248 shares left1x usual sizeFiling
- 2 Form 4 saleRoutineJun 26 +8 days
Sold 15,000 shares at $45.64 ($685k)
Flynn Sean C., Chief Legal Officer
10b5-1 planSold 90.1% of holdings ($760k position)1,647 shares left1x usual sizeFiling
- 3 Form 4 saleRoutineJun 26 same day
Sold 10,000 shares at $45.00 ($450k)
Hopper Jonathan Mark, Chief Medical Officer
10b5-1 planSold 11.7% of holdings ($3.9M position)75,753 shares left1x usual sizeFiling
- 4 Form 4 saleRoutineJun 26 same day
Sold 5,000 shares at $44.75 ($224k)
Mara Joseph Anthony Jr, Chief Financial Officer
10b5-1 planSold 23.8% of holdings ($940k position)16,009 shares left1x usual sizeFiling
- 5 Form 4 saleRoutineJun 26 same day
Sold 2,732 shares at $44.90 ($123k)
Siegal Jonathan, Principal Accounting Officer
10b5-1 planSold 75.5% of holdings ($162k position)886 shares left2.4x usual sizeFiling
- 6 Form 4 saleRoutineJul 30 +34 days
Sold 4,500 shares at $48.90 ($220k)
Siegal Jonathan, Principal Accounting Officer
10b5-1 planSold 80.7% of holdings ($273k position)1,078 shares left2.6x usual sizeFiling
- 7 Form 4 saleRoutineAug 3 +4 days
Sold 10,000 shares at $46.84 ($468k)
Halpin Michael, Chief Operating Officer
10b5-1 planSold 37.9% of holdings ($1.2M position)16,394 shares left1x usual sizeFiling
- 8 Form 4 saleRoutineAug 12 +9 days
Sold 7,000 shares at $44.53 ($312k)
Mclaughlin Kevin F, Director
10b5-1 planSold 27.7% of holdings ($1.1M position)18,300 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales, notices and lockups (169)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Mclaughlin Kevin F | Director | Form 4 sale | 7,000 | $312k | 27.7% | Routine | SEC |
| Aug 3, 2026 | Halpin Michael | Chief Operating Officer | Form 4 sale | 10,000 | $468k | 37.9% | Routine | SEC |
| Jul 30, 2026 | Siegal Jonathan | Principal Accounting Officer | Form 4 sale | 4,500 | $220k | 80.7% | Routine | SEC |
| Jun 26, 2026 | Siegal Jonathan | Principal Accounting Officer | Form 4 sale | 2,732 | $123k | 75.5% | Routine | SEC |
| Jun 26, 2026 | Mara Joseph Anthony Jr | Chief Financial Officer | Form 4 sale | 5,000 | $224k | 23.8% | Routine | SEC |
| Jun 26, 2026 | Hopper Jonathan Mark | Chief Medical Officer | Form 4 sale | 10,000 | $450k | 11.7% | Routine | SEC |
| Jun 26, 2026 | Flynn Sean C. | Chief Legal Officer | Form 4 sale | 15,000 | $685k | 90.1% | Routine | SEC |
| Jun 18, 2026 | Halpin Michael | Chief Operating Officer | Form 4 sale | 10,000 | $402k | 38.1% | Routine | SEC |
| Jun 18, 2026 | Flynn Sean C. | Chief Legal Officer | Form 4 sale | 15,000 | $603k | 90.1% | Routine | SEC |
| Jun 2, 2026 | Hopper Jonathan Mark | Chief Medical Officer | Form 4 sale | 4,375 | $153k | 5.5% | Routine | SEC |
| May 13, 2026 | Mclaughlin Kevin F | Director | Form 4 sale | 7,000 | $230k | 27.7% | Routine | SEC |
| May 11, 2026 | Wotton Paul K | Director | Form 4 sale | 10,000 | $327k | 34.7% | Unusual | SEC |
| May 7, 2026 | Mara Joseph Anthony Jr | Chief Financial Officer | Form 4 sale | 5,000 | $203k | 19.2% | Routine | SEC |
| May 7, 2026 | Siegal Jonathan | Principal Accounting Officer | Form 4 sale | 4,855 | $188k | 81.3% | Unusual | SEC |
| Apr 2, 2026 | Hopper Jonathan Mark | Chief Medical Officer | Form 4 sale | 3,472 | $122k | 4.4% | Routine | SEC |
| Mar 23, 2026 | Hagen Heidi | Director | Form 4 sale | 15,000 | $486k | 32.0% | Routine | SEC |
| Mar 2, 2026 | Flynn Sean C. | Chief Legal Officer | Form 4 sale | 21,421 | $754k | 94.4% | Routine | SEC |
| Mar 2, 2026 | Halpin Michael | Chief Operating Officer | Form 4 sale | 10,305 | $364k | 39.1% | Routine | SEC |
| Feb 11, 2026 | Mclaughlin Kevin F | Director | Form 4 sale | 7,000 | $243k | 31.7% | Routine | SEC |
| Jan 7, 2026 | Halpin Michael | Chief Operating Officer | Form 4 sale | 10,000 | $405k | 38.3% | Routine | SEC |
| Dec 3, 2025 | Wotton Paul K | Director | Form 4 sale | 5,000 | $190k | 16.3% | No plan | SEC |
| Dec 2, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Form 4 sale | 1,652 | $65k | 2.4% | Routine | SEC |
| Nov 11, 2025 | Halpin Michael | Chief Operating Officer | Form 4 sale | 2,642 | $107k | 14.2% | Routine | SEC |
| Nov 10, 2025 | Mclaughlin Kevin F | Director | Form 4 sale | 7,000 | $270k | 31.7% | Routine | SEC |
| Nov 6, 2025 | Halpin Michael | Chief Operating Officer | Form 4 sale | 7,358 | $298k | 31.6% | Routine | SEC |
| Sep 2, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Form 4 sale | 10,000 | $358k | 13.1% | Routine | SEC |
| Aug 6, 2025 | Mclaughlin Kevin F | Director | Form 4 sale | 7,000 | $251k | 31.7% | Routine | SEC |
| Jun 2, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Form 4 sale | 10,000 | $401k | 13.1% | Routine | SEC |
| May 15, 2025 | Colangelo Dominick | President and CEO | Form 4 sale | 28,125 | $1.2M | 9.7% | Routine | SEC |
| May 7, 2025 | Mclaughlin Kevin F | Director | Form 4 sale | 7,000 | $280k | 31.7% | Routine | SEC |
| Apr 10, 2025 | Colangelo Dominick | President and CEO | Form 4 sale | 49,700 | $2.1M | 16.0% | Routine | SEC |
| Mar 13, 2025 | Colangelo Dominick | President and CEO | Form 4 sale | 53,183 | $2.4M | 17.0% | Routine | SEC |
| Mar 3, 2025 | Halpin Michael | Chief Operating Officer | Form 4 sale | 10,000 | $495k | 39.2% | Routine | SEC |
| Mar 3, 2025 | Hagen Heidi | Director | Form 4 sale | 9,000 | $446k | 23.9% | Routine | SEC |
| Mar 3, 2025 | Mara Joseph Anthony Jr | Chief Financial Officer | Form 4 sale | 9,000 | $446k | 39.2% | Routine | SEC |
| Mar 3, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Form 4 sale | 10,000 | $495k | 13.1% | Routine | SEC |
| Feb 25, 2025 | Flynn Sean C. | Chief Legal Officer | Form 4 sale | 1,669 | $87k | 68.8% | Routine | SEC |
| Feb 25, 2025 | Siegal Jonathan | Principal Accounting Officer | Form 4 sale | 1,137 | $59k | 48.5% | Routine | SEC |
| Feb 20, 2025 | Flynn Sean C. | Chief Legal Officer | Form 4 sale | 3,835 | $220k | 83.5% | Routine | SEC |
| Feb 19, 2025 | Siegal Jonathan | Principal Accounting Officer | Form 4 sale | 1,710 | $97k | 58.6% | Routine | SEC |
| Feb 12, 2025 | Mclaughlin Kevin F | Director | Form 4 sale | 7,000 | $388k | 37.0% | Routine | SEC |
| Feb 5, 2025 | Zerbe Robert L Md | Director | Form 4 sale | 2,500 | $156k | 8.6% | Routine | SEC |
| Feb 5, 2025 | Siegal Jonathan | Principal Accounting Officer | Form 4 sale | 1,092 | $68k | 47.5% | Routine | SEC |
| Jan 28, 2025 | Siegal Jonathan | Principal Accounting Officer | Form 4 sale | 3,908 | $242k | 76.4% | Unusual | SEC |
| Dec 4, 2024 | Wotton Paul K | Director | Form 4 sale | 2,600 | $153k | 8.7% | No plan | SEC |
| Dec 4, 2024 | Wotton Paul K | Director | Form 144 notice | 2,600 | $218k | Notice | SEC | |
| Dec 2, 2024 | Hopper Jonathan Mark | Chief Medical Officer | Form 4 sale | 10,000 | $587k | 14.6% | Routine | SEC |
| Dec 2, 2024 | Hopper Jonathan Mark | Officer | Form 144 notice | 10,000 | $580k | Notice | SEC | |
| Nov 22, 2024 | Zerbe Robert L Md | Director | Form 4 sale | 2,500 | $150k | 8.6% | Routine | SEC |
| Nov 22, 2024 | Zerbe Robert L Md | Director | Form 144 notice | 2,500 | $150k | Notice | SEC | |
| Nov 14, 2024 | Colangelo Dominick | President and CEO | Form 4 sale | 35,000 | $1.9M | 13.7% | Routine | SEC |
| Nov 13, 2024 | Mclaughlin Kevin F | Director | Form 4 sale | 7,000 | $389k | 37.0% | Routine | SEC |
| Nov 12, 2024 | Zerbe Robert L Md | Director | Form 4 sale | 5,000 | $281k | 15.8% | Routine | SEC |
| Oct 17, 2024 | Colangelo Dominick | President and CEO | Form 4 sale | 35,000 | $1.4M | 13.7% | Routine | SEC |
| Oct 16, 2024 | Gilman Steven C | Director | Form 4 sale | 5,833 | $241k | 34.7% | Routine | SEC |
| Oct 2, 2024 | Gilman Steven C | Director | Form 4 sale | 5,833 | $235k | 34.7% | Routine | SEC |
| Oct 1, 2024 | Siegal Jonathan | Principal Accounting Officer | Form 4 sale | 568 | $24k | 33.6% | Routine | SEC |
| Sep 18, 2024 | Gilman Steven C | Director | Form 4 sale | 5,834 | $266k | 34.7% | Routine | SEC |
| Sep 12, 2024 | Colangelo Dominick | President and CEO | Form 4 sale | 35,000 | $1.5M | 13.7% | Routine | SEC |
| Sep 4, 2024 | Gilman Steven C | Director | Form 4 sale | 5,000 | $243k | 31.3% | Routine | SEC |
| Sep 3, 2024 | Hopper Jonathan Mark | Chief Medical Officer | Form 4 sale | 10,000 | $498k | 14.7% | Routine | SEC |
| Aug 15, 2024 | Colangelo Dominick | President and CEO | Form 4 sale | 35,000 | $1.6M | 13.7% | Routine | SEC |
| Aug 7, 2024 | Mclaughlin Kevin F | Director | Form 4 sale | 7,000 | $322k | 37.0% | Routine | SEC |
| Jul 18, 2024 | Colangelo Dominick | President and CEO | Form 4 sale | 35,000 | $1.8M | 13.7% | Routine | SEC |
| Jul 16, 2024 | Flynn Sean C. | Chief Legal Officer | Form 4 sale | 15,000 | $783k | 95.5% | Routine | SEC |
| Jul 12, 2024 | Mara Joseph Anthony Jr | Chief Financial Officer | Form 4 sale | 5,000 | $250k | 25.7% | Routine | SEC |
| Jul 5, 2024 | Siegal Jonathan | Principal Accounting Officer | Form 4 sale | 545 | $25k | 34.5% | Routine | SEC |
| Jun 24, 2024 | Flynn Sean C. | Chief Legal Officer | Form 4 sale | 15,000 | $677k | 96.9% | Routine | SEC |
| Jun 13, 2024 | Colangelo Dominick | President and CEO | Form 4 sale | 35,000 | $1.5M | 13.7% | Routine | SEC |
| May 20, 2024 | Hopper Jonathan Mark | Chief Medical Officer | Form 4 sale | 10,000 | $500k | 14.7% | Routine | SEC |
| May 16, 2024 | Colangelo Dominick | President and CEO | Form 4 sale | 35,000 | $1.7M | 13.7% | Routine | SEC |
| Apr 18, 2024 | Colangelo Dominick | President and CEO | Form 4 sale | 35,000 | $1.6M | 15.2% | Routine | SEC |
| Mar 27, 2024 | Zerbe Robert L Md | Director | Form 4 sale | 3,278 | $169k | 12.3% | Routine | SEC |
| Mar 14, 2024 | Colangelo Dominick | President and CEO | Form 4 sale | 35,000 | $1.6M | 15.2% | Routine | SEC |
| Mar 11, 2024 | Halpin Michael | Chief Operating Officer | Form 4 sale | 7,874 | $352k | 89.2% | Routine | SEC |
| Mar 8, 2024 | Flynn Sean C. | SVP, General Counsel | Form 4 sale | 8,115 | $368k | 98.0% | Unusual | SEC |
| Mar 7, 2024 | Siegal Jonathan | Principal Accounting Officer | Form 4 sale | 1,634 | $74k | 53.9% | Unusual | SEC |
| Feb 20, 2024 | Zerbe Robert L Md | Director | Form 4 sale | 722 | $36k | 3.0% | Routine | SEC |
| Feb 20, 2024 | Zerbe Robert L Md | Director | Form 144 notice | 722 | $36k | Notice | SEC | |
| Feb 15, 2024 | Colangelo Dominick | President and CEO | Form 4 sale | 35,000 | $1.7M | 16.7% | Routine | SEC |
| Feb 15, 2024 | Colangelo Dominick | Officer, Director | Form 144 notice | 17,500 | $855k | Notice | SEC | |
| Feb 14, 2024 | Colangelo Dominick | Officer, Director | Form 144 notice | 17,500 | $822k | Notice | SEC | |
| Jan 29, 2024 | Zerbe Robert L Md | Director | Form 4 sale | 2,300 | $102k | 9.0% | No plan | SEC |
| Jan 29, 2024 | Zerbe Robert L Md | Director | Form 144 notice | 2,300 | $102k | Notice | SEC | |
| Jan 25, 2024 | Zerbe Robert L Md | Director | Form 4 sale | 200 | $9k | 0.8% | Routine | SEC |
| Jan 25, 2024 | Zerbe Robert L Md | Director | Form 144 notice | 200 | $9k | Notice | SEC | |
| Jan 22, 2024 | Zerbe Robert L Md | Director | Form 4 sale | 8,000 | $335k | 23.6% | Unusual | SEC |
| Jan 22, 2024 | Zerbe Robert L Md | Director | Form 144 notice | 8,000 | $335k | Notice | SEC | |
| Jan 18, 2024 | Colangelo Dominick | President and CEO | Form 4 sale | 33,452 | $1.3M | 16.4% | Routine | SEC |
| Jan 18, 2024 | Colangelo Dominick | Officer, Director | Form 144 notice | 16,726 | $645k | Notice | SEC | |
| Jan 17, 2024 | Colangelo Dominick | Officer, Director | Form 144 notice | 16,726 | $635k | Notice | SEC | |
| Jan 12, 2024 | Zerbe Robert L Md | Director | Form 4 sale | 2,200 | $84k | 6.6% | Routine | SEC |
| Jan 12, 2024 | Zerbe Robert L Md | Director | Form 144 notice | 2,200 | $84k | Notice | SEC | |
| Dec 14, 2023 | Flynn Sean C. | SVP, General Counsel | Form 4 sale | 1,538 | $53k | 25.6% | Unusual | SEC |
| Dec 14, 2023 | Wotton Paul K | Director | Form 4 sale | 5,000 | $187k | 15.7% | No plan | SEC |
| Dec 14, 2023 | Colangelo Dominick | President and CEO | Form 4 sale | 24,000 | $854k | 12.4% | Routine | SEC |
| Dec 14, 2023 | Colangelo Dominick | Officer, Director | Form 144 notice | 12,000 | $445k | Notice | SEC | |
| Dec 14, 2023 | Wotton Paul K | Director | Form 144 notice | 5,000 | $185k | Notice | SEC | |
| Dec 13, 2023 | Colangelo Dominick | Officer, Director | Form 144 notice | 12,000 | $408k | Notice | SEC | |
| Dec 13, 2023 | Flynn Sean C. | Officer | Form 144 notice | 1,538 | $53k | Notice | SEC | |
| Dec 7, 2023 | Colangelo Dominick | President and CEO | Form 4 sale | 24,397 | $833k | 12.1% | Routine | SEC |
| Dec 7, 2023 | Colangelo Dominick | Officer, Director | Form 144 notice | 12,000 | $406k | Notice | SEC | |
| Dec 6, 2023 | Colangelo Dominick | Officer, Director | Form 144 notice | 12,397 | $427k | Notice | SEC | |
| Nov 30, 2023 | Halpin Michael | Chief Operating Officer | Form 4 sale | 17,447 | $618k | 95.5% | Routine | SEC |
| Nov 30, 2023 | Halpin Michael | Officer | Form 144 notice | 17,447 | $622k | Notice | SEC | |
| Nov 20, 2023 | Hopper Jonathan Mark | Chief Medical Officer | Form 4 sale | 5,000 | $182k | 8.6% | Routine | SEC |
| Nov 20, 2023 | Hopper Jonathan Mark | Officer | Form 144 notice | 5,000 | $181k | Notice | SEC | |
| Nov 15, 2023 | Zerbe Robert L Md | Director | Form 4 sale | 300 | $11k | 0.9% | Routine | SEC |
| Nov 15, 2023 | Siegal Jonathan | Principal Accounting Officer | Form 4 sale | 662 | $25k | 33.7% | Unusual | SEC |
| Nov 15, 2023 | Zerbe Robert L Md | Director | Form 144 notice | 300 | $11k | Notice | SEC | |
| Nov 15, 2023 | Siegal Jonathan | Officer | Form 144 notice | 662 | $25k | Notice | SEC | |
| Jul 14, 2023 | Zerbe Robert L Md | Director | Form 4 sale | 1,000 | $39k | 2.9% | Routine | SEC |
| Jul 14, 2023 | Zerbe Robert L Md | Director | Form 144 notice | 1,000 | $39k | Notice | SEC | |
| Jun 22, 2023 | Zerbe Robert L Md | Director | Form 4 sale | 3,000 | $108k | 8.0% | Routine | SEC |
| Jun 22, 2023 | Zerbe Robert L Md | Director | Form 144 notice | 3,000 | $108k | Notice | SEC | |
| Feb 2, 2023 | Siegal Jonathan | Principal Accounting Officer | Form 4 sale | 330 | $10k | 32.8% | Unusual | SEC |
| Jan 10, 2023 | Colangelo Dominick | President and CEO | Form 4 sale | 39,938 | $1.1M | 20.3% | Plan not stated | SEC |
| Oct 14, 2022 | Siegal Jonathan | Principal Accounting Officer | Form 4 sale | 331 | $8k | 27.4% | Unusual | SEC |
| Apr 29, 2022 | Gilman Steven C | Director | Form 4 sale | 900 | $28k | 14.8% | Plan not stated | SEC |
| Mar 1, 2022 | Hopper Jonathan Mark | Chief Medical Officer | Form 4 sale | 16,738 | $693k | 25.4% | Unusual | SEC |
| Dec 22, 2021 | Hopper Jonathan Mark | Chief Medical Officer | Form 4 sale | 15,881 | $637k | 26.7% | Unusual | SEC |
| Nov 29, 2021 | Gilman Steven C | Director | Form 4 sale | 5,000 | $196k | 58.8% | Unusual | SEC |
| Oct 27, 2021 | Gilman Steven C | Director | Form 4 sale | 5,000 | $253k | 58.8% | Unusual | SEC |
| Oct 26, 2021 | Halpin Michael | Chief Operating Officer | Form 4 sale | 10,000 | $506k | 63.7% | Unusual | SEC |
| Sep 30, 2021 | Gilman Steven C | Director | Form 4 sale | 5,000 | $244k | 58.8% | Unusual | SEC |
| Aug 27, 2021 | Flynn Sean C. | VP, General Counsel | Form 4 sale | 7,200 | $397k | 74.9% | Unusual | SEC |
| Aug 16, 2021 | Halpin Michael | Chief Operating Officer | Form 4 sale | 15,000 | $720k | 72.7% | Unusual | SEC |
| Jul 21, 2021 | Flynn Sean C. | VP, General Counsel | Form 4 sale | 2,800 | $154k | 53.7% | Unusual | SEC |
| Jul 15, 2021 | Flynn Sean C. | VP, General Counsel | Form 4 sale | 10,000 | $512k | 80.5% | Unusual | SEC |
| Jul 12, 2021 | Halpin Michael | Chief Operating Officer | Form 4 sale | 20,000 | $1.1M | 78.1% | Unusual | SEC |
| Jun 30, 2021 | Hopper Jonathan Mark | Chief Medical Officer | Form 4 sale | 134 | $8k | 0.3% | Plan not stated | SEC |
| May 14, 2021 | Wotton Paul K | Director | Form 4 sale | 5,000 | $253k | 15.8% | Plan not stated | SEC |
| May 12, 2021 | Wotton Paul K | Director | Form 4 sale | 15,648 | $781k | 33.1% | Unusual | SEC |
| Apr 19, 2021 | Colangelo Dominick | President and CEO | Form 4 sale | 40,000 | $2.3M | 21.9% | Plan not stated | SEC |
| Mar 30, 2021 | Hopper Jonathan Mark | Chief Medical Officer | Form 4 sale | 17,924 | $921k | 31.8% | Unusual | SEC |
| Mar 29, 2021 | Colangelo Dominick | President and CEO | Form 4 sale | 40,000 | $2M | 19.3% | Plan not stated | SEC |
| Mar 1, 2021 | Colangelo Dominick | President and CEO | Form 4 sale | 40,000 | $1.9M | 16.2% | Plan not stated | SEC |
| Dec 21, 2020 | Hopper Jonathan Mark | Chief Medical Officer | Form 4 sale | 24,235 | $643k | 50.9% | Unusual | SEC |
| Dec 21, 2020 | Halpin Michael | Chief Operating Officer | Form 4 sale | 30,000 | $788k | 92.9% | Unusual | SEC |
| Nov 23, 2020 | Zerbe Robert L Md | Director | Form 4 sale | 17,500 | $412k | 35.5% | Unusual | SEC |
| Jun 23, 2020 | Halpin Michael | Chief Operating Officer | Form 4 sale | 14,751 | $221k | 90.1% | Unusual | SEC |
| Jun 16, 2020 | Halpin Michael | Chief Operating Officer | Form 4 sale | 4,002 | $60k | 71.2% | Unusual | SEC |
| Nov 11, 2019 | Halpin Michael | Chief Operating Officer | Form 4 sale | 15,047 | $279k | 93.6% | Unusual | SEC |
| Oct 1, 2019 | Colangelo Dominick | President and CEO | Form 4 sale | 58,125 | $865k | 34.0% | Unusual | SEC |
| Aug 14, 2019 | Michel Gerard J | CFO and VP, Corp. Development | Form 4 sale | 17,000 | $283k | 12.1% | Plan not stated | SEC |
| Jul 15, 2019 | Michel Gerard J | CFO and VP, Corp. Development | Form 4 sale | 17,000 | $335k | 12.1% | Plan not stated | SEC |
| Jun 10, 2019 | Michel Gerard J | CFO and VP, Corp. Development | Form 4 sale | 17,500 | $273k | 12.5% | Plan not stated | SEC |
| May 13, 2019 | Michel Gerard J | CFO and VP, Corp. Development | Form 4 sale | 17,500 | $298k | 12.5% | Plan not stated | SEC |
| May 1, 2019 | Gilman Steven C | Director | Form 4 sale | 7,500 | $126k | 100.0% | Unusual | SEC |
| Apr 8, 2019 | Michel Gerard J | CFO and VP, Corp. Development | Form 4 sale | 15,625 | $276k | 11.3% | Plan not stated | SEC |
| Mar 11, 2019 | Michel Gerard J | CFO and VP, Corp. Development | Form 4 sale | 10,000 | $200k | 7.6% | Plan not stated | SEC |
| Feb 28, 2019 | Gilman Steven C | Director | Form 4 sale | 7,500 | $135k | 100.0% | Unusual | SEC |
| Feb 11, 2019 | Michel Gerard J | CFO and VP, Corp. Development | Form 4 sale | 10,000 | $171k | 7.0% | Plan not stated | SEC |
| Jan 14, 2019 | Michel Gerard J | CFO and VP, Corp. Development | Form 4 sale | 8,711 | $150k | 5.8% | Plan not stated | SEC |
| Jan 2, 2019 | Wotton Paul K | Director | Form 4 sale | 22,500 | $379k | 100.0% | Unusual | SEC |
| Dec 10, 2018 | Michel Gerard J | CFO and VP, Corp. Development | Form 4 sale | 15,625 | $263k | 9.4% | Plan not stated | SEC |
| Dec 3, 2018 | Gilman Steven C | Director | Form 4 sale | 8,500 | $151k | 100.0% | Unusual | SEC |
| Nov 12, 2018 | Michel Gerard J | CFO and VP, Corp. Development | Form 4 sale | 15,000 | $239k | 9.0% | Plan not stated | SEC |
| Nov 6, 2018 | Colangelo Dominick | President and CEO | Form 4 sale | 50,000 | $770k | 39.9% | Unusual | SEC |
| Oct 15, 2018 | Michel Gerard J | CFO and VP, Corp. Development | Form 4 sale | 15,000 | $190k | 9.0% | Plan not stated | SEC |
| Oct 4, 2018 | Colangelo Dominick | President and CEO | Form 4 sale | 75,000 | $1.1M | 49.9% | Unusual | SEC |
| Sep 10, 2018 | Michel Gerard J | CFO and VP, Corp. Development | Form 4 sale | 15,000 | $185k | 9.0% | Plan not stated | SEC |
| Sep 4, 2018 | Gilman Steven C | Director | Form 4 sale | 9,000 | $108k | 100.0% | Unusual | SEC |
| Jun 18, 2018 | Wotton Paul K | Director | Form 4 sale | 30,000 | $362k | 100.0% | Unusual | SEC |
| May 17, 2018 | Colangelo Dominick | President and CEO | Form 4 sale | 28,886 | $405k | 28.2% | Unusual | SEC |
| May 10, 2018 | Orlando Daniel | Chief Operating Officer | Form 4 sale | 34,183 | $446k | 73.2% | Unusual | SEC |
| Mar 28, 2016 | Blutt Mitchell J Md | 10% owner | Form 4 sale | 120,000 | $647k | 5.1% | Plan not stated | SEC |
| Jan 4, 2012 | Durbin Scott | CFO | Form 4 sale | 40,000 | $72k | 100.0% | Unusual | SEC |
| May 12, 2006 | Hock Janet Mary | VP Global Research & CSO | Form 4 sale | 37,139 | $50k | 50.0% | Unusual | SEC |